Login to Your Account



$262M+ Auxilium-Asahi Kasei Deal Expands Xiaflex Market

By Tom Wall


Wednesday, March 23, 2011
Auxilium Pharmaceuticals Inc. has added another piece to the expanding global market for Xiaflex (collagenase Clostridium histolyticum) with an agreement that gives Asahi Kasei Pharma Corp., of Tokyo, exclusive rights to commercialize Xiaflex for the treatment of Dupuytren's contracture and Peyronie's disease in Japan.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription